2026 Annual Meeting | C113 - Treatment Options in Pain

Date Monday 04/20/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Narayan R. Kissoon, MD

Topic(s) Pain

Learning Objectives Participants should be able to appraise the treatment options available for pain and formulate comprehensive multi-modal care plans that employ behavioral treatments, medications, and/or interventions when appropriate for patients with chronic pain. They will identify clinical features that can guide medication selection and apply evidence-based pain phenotyping to cases commonly seen by neurologists in clinical practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 03:35 PM CDT	Introduction	Introduction of Faculty Narayan R. Kissoon, MD
03:35 PM - 04:10 PM CDT	Speaker	Accessible Behavioral Treatments for Pain – Beyond CBT with Novel Digital Health Delivery
04:10 PM - 04:45 PM CDT	Speaker	Demystifying Interventional Treatments for Pain Nathaniel M. Schuster, MD
04:45 PM - 05:20 PM CDT	Speaker	Rapid Fire Cases with Pain Phenotyping to Guide Treatment Selection Narayan R. Kissoon, MD
05:20 PM - 05:30 PM CDT	Q&A	Questions and Answers Narayan R. Kissoon, MD, Nathaniel M. Schuster, MD,

Faculty Disclosures
Narayan R. Kissoon, MD	Dr. Kissoon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex Pharmaceuticals. The institution of Dr. Kissoon has received research support from Nevro Corporation. The institution of Dr. Kissoon has received research support from Novo Nordisc Foundation. The institution of Dr. Kissoon has received research support from Shiratronics. Dr. Kissoon has received publishing royalties from a publication relating to health care.
Nathaniel M. Schuster, MD	Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Schedule 1 Therapeutics. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas. Dr. Schuster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lohocla Research Corporation. Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapport Therapeutics. Dr. Schuster has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly & Co. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Averitas. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. Dr. Schuster has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms and the State of California. The institution of Dr. Schuster has received research support from Migraine Research Foundation. The institution of Dr. Schuster has received research support from UCSD Academic Senate. The institution of Dr. Schuster has received research support from NINDS 1 R01 AT012048-01A1. The institution of Dr. Schuster has received research support from NCCIH 5R00AT009466-04. The institution of Dr. Schuster has received research support from NCCIH U24 NS115714. The institution of Dr. Schuster has received research support from NIH/HEAL EN21-01. The institution of Dr. Schuster has received research support from ShiraTronics.
	No disclosure on file

��ɫ��

��ɫ��